PSB-CB-27
PSB-CB-27 is a potent and selective GPR18 inhibitor with an IC50 of 0.65 μM. PSB-CB-27 shows selectivity over Human GPR55, Human CB1 receptor, and Human CB2 receptor. PSB-CB-27 leads to a complete blockade of Δ9-Tetrahydrocannabinol (THC)-induced GPR18 activation. PSB-CB-27 can be used for inflammatory diseases and cancer immunotherapy research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2237222-16-9
- Formule: C25H27ClN2O3S
- Masse moléculaire:471.01
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
GPR18 0.62 μM (IC50) |
Chemical Information
-
CAS No. 2237222-16-9
-
Masse moléculaire 471.01
-
Formule C25H27ClN2O3S
-
SMILES
O=C1N2C(SCCC2)=N/C1=C\C3=CC(OCCCCCCOC4=CC=C(C=C4)Cl)=CC=C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)